METHOD FOR DIAGNOSING METABOLIC DISORDER

METHOD FOR MEASURING MINERALOCORTICOID RECEPTOR ACTIVITY

Uses of 5-Aminovaleric Acid Betaine and Compositions Related Thereto

METHOD OF TREATING OBESITY WITH PRECISION MEDICINE PANEL

INDIVIDUALIZED LIFESTYLE INTERVENTION FOR OBESITY MANAGEMENT BASED ON OBESITY PHENOTYPES

COMPOSITIONS AND METHODS FOR SUPPRESSING AND/OR TREATING METABOLIC DISEASES AND/OR A CLINICAL CONDITION THEREOF

HUMAN INSULIN C-ALPHA-PEPTIDES AND METHODS OF USE

Cholesterol reducing compositions and methods of use thereof

AUTOANTIBODIES AS BIOMARKERS FOR LIPODYSTROPHY

MENTSH analogs as therapeutics for diabetes, obesity, and their associated diseases and complications

METHODS AND MATERIALS FOR ASSESSING AND TREATING OBESITY

Uses of 5-Aminovaleric Acid Betaine and Compositions Related Thereto

METHOD FOR MAKING A FINDING FOR THE FUNCTIONALITY OF AN ANOREXIGENIC SIGNAL PATH FOR A PATIENT

COMPOSITIONS AND METHODS FOR PREDICTING AND PROMOTING WEIGHT LOSS IN PATIENTS WITH LOW AMY1 COPY NUMBERS

METHODS AND COMPOSITIONS FOR TREATING OBESITY AND/OR DIABETES AND FOR IDENTIFYING CANDIDATE TREATMENT AGENTS

FUSION PROTEIN AND HIGH-DENSITY LIPOPROTEIN MEASUREMENT KIT USING SAME

TMA-formation inhibitor treatment for elevated TMA-containing compound diseases

Method for the Diagnosis of Gaucher's Disease

COMPOSITIONS AND METHODS FOR SUPPRESSING AND/OR TREATING METABOLIC DISEASES AND/OR A CLINICAL CONDITION THEREOF

MENTSH analogs as therapeutics for diabetes, obesity, and their associated diseases and complications

Proprotein convertase subtilisin/kexin type 1 (PCSK1) variants and uses thereof

METHOD FOR MEASURING THE TRIMETHYLAMINE N-OXIDE PRODUCTION CAPACITY IN AN INDIVIDUAL

OXYGENATED CHOLESTEROL SULFATES FOR THERAPY OF DISORDERS CAUSED BY AT LEAST ONE OF ATTENUATED LEPTIN ACTIVITY AND A LIPID STORAGE DISORDER

Cholesterol reducing compositions and methods of use thereof

Determination method and kit for determining possibility of reduced renal function

Methods and materials for assessing and treating obesity

ICAM-1 MARKER AND APPLICATION THEREOF

Eyewear with proximity sensors

METHODS OF DIAGNOSING A DISEASE AND METHODS OF MONITORING TREATMENT OF A DISEASE BY QUANTIFYING A NON-REDUCING END GLYCAN RESIDUAL COMPOUND AND COMPARING TO A SECOND BIOMARKER

A METHOD FOR DIAGNOSING METABOLIC DISORDER

Method for predicting the risk of obesity in a subject

Method for measuring cholesterol uptake capacity of lipoproteins

ANGPTL8 assay and uses thereof

Identification and monitoring of apoptosis inhibitor of macrophage

BIOMARKERS FOR PREDICTING DEGREE OF WEIGHT LOSS

OXYGENATED CHOLESTEROL SULFATES FOR THERAPY OF DISORDERS CAUSED BY AT LEAST ONE OF ATTENUATED LEPTIN ACTIVITY AND A LIPID STORAGE DISORDER

Methods for Treating Obesity of a Subject Suffering from Obesity

Tissue-specific exosomes as biomarkers

COMPOSITION CONTAINING INTRAVAGINAL MICROORGANISMS

METHOD OF LIPID ASSAY AND REAGENT FOR USE THEREIN

BIOMARKERS FOR PREDICTING DEGREE OF WEIGHT LOSS

Trimethylamine-containing compounds for diagnosis and prediction of disease

OBESITY-RELATED DISEASE THERAPEUTIC AGENT BY HEPATIC SECRETORY METABOLIC REGULATOR INHIBITORY ACTION

Generation of brown adipose tissue from pluripotent stem cells in vitro

MENTSH analogs as therapeutics for diabetes, obesity, and their associated diseases and complications

Methods and compositions for treating hypertriglyceridemia

METHOD OF DETECTION OF CLINICALLY SIGNIFICANT POST-PRANDIAL HYPERGLYCEMIA IN NORMOGLYCEMIC PATIENTS

OXYGENATED CHOLESTEROL SULFATES FOR THERAPY OF DISORDERS CAUSED BY AT LEAST ONE OF ATTENUATED LEPTIN ACTIVITY AND A LIPID STORAGE DISORDER

OBESITY RISK DIAGNOSIS KIT AND METHOD FOR ANALYZING RISK OF OBESITY ONSET

Colorimetric filter paper assay for rapid monitoring of cholesterol level

Methods and compositions for treating obesity and/or diabetes and for identifying candidate treatment agents

Method for preventing an infection by a virus

Method for determining fat free body mass

MILK FAT GLOBULE EPIDERMAL GROWTH FACTOR 8 REGULATES FATTY ACID UPTAKE

Method for the diagnosis of Gaucher's disease

Methods of diagnosing mucopolysaccharidosis (MPS) I and methods of monitoring treatment of MPS by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker

METHOD FOR ASSISTING DETERMINATION OF TYPE III HYPERLIPIDEMIA

Diagnostic method and biomarker for lifestyle disease

Method for predicting the risk of obesity in a subject

GLYCEROL-3-PHOSPHATE PHOSPHATASE ACTIVATORS

SYSTEMS AND METHODS FOR CHARACTERIZATION OF HYPERTRIGLYCERIDEMIA

OBSTRUCTIVE SLEEP APNEA (OSA) BIOMARKER PANEL

METHOD OF DETECTION OF OCCULT PANCREATIC BETA CELL DYSFUNCTION IN NORMOGLYCEMIC PATIENTS

BIOMARKERS FOR PREDICTING DEGREE OF WEIGHT LOSS IN FEMALE SUBJECTS

Method and system for microbiome-derived characterization, diagnostics, and therapeutics for cardiovascular disease conditions

Method and system for microbiome-derived characterization, diagnostics, and therapeutics for cardiovascular disease conditions

Adipocyte-derived exosomes, and compositions, kits, and methods of using the same for detection and screening

BIOMARKERS FOR PREDICTING DEGREE OF WEIGHT LOSS IN MALE SUBJECTS

Method and system for microbiome-derived characterization, diagnostics, and therapeutics for cardiovascular disease conditions

Methods of diagnosing and treating cancer comprising ME1

Use of human small leucine zipper protein in adipocyte differentiation procedure

Method and system for microbiome-derived characterization, diagnostics, and therapeutics for cardiovascular disease conditions

Compilation of detection reagents, in-vitro method for detecting mutated leptin, and use of a detection reagent

Preparation of lipemic plasma or serum samples for the determination of a lipid interference

Methods for predicting glucoregulatory dysfunction via diacylglycerol fatty acid species concentrations

METHOD OF LIPID ASSAY AND REAGENT FOR USE THEREIN

BIOMARKERS FOR PREDICTING DEGREE OF WEIGHT LOSS

Screening Method For Compound Having Obesity Preventive Or Therapeutic Activity

Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity

METHOD AND SYSTEM FOR MICROBIOME-DERIVED CHARACTERIZATION, DIAGNOSTICS, AND THERAPEUTICS FOR CARDIOVASCULAR DISEASE CONDITIONS

Method for measuring cholesterol uptake capacity of lipoproteins

OXYGENATED CHOLESTEROL SULFATES FOR THERAPY OF DISORDERS CAUSED BY AT LEAST ONE OF ATTENUATED LEPTIN ACTIVITY AND A LIPID STORAGE DISORDER

Molecular Probes for Detecting Lipids

VACCINES AND MONOCLONAL ANTIBODIES TARGETING TRUNCATED VARIANTS OF OSTEOPONTIN AND USES THEREOF

Methods of Determining Efficacy of Therapy For Niemann-Pick C Disease And Related Disorders

Progranulin (PGRN) and its derivatives for diagnosis and treatment of lysosomal storage diseases

MARKER OF NEUROPATHIC GAUCHER'S DISEASE AND METHODS OF USE THEREOF

PCSK9 QUANTIFICATION BY IMMUNODETECTION

Biomarkers of mineralocorticoid receptor activation

Methods of determining the presence, identity, and/or severity of mucopolysaccharidosis (MPS) VI and IVA

Method for preventing infection by a virus

Methods of treating metabolic disorders

Method and system for microbiome-derived characterization, diagnostics and therapeutics for cardiovascular disease conditions

Compositions and Methods for Evaluating Metabolic Syndrome and Related Diseases

DETECTION OF ALPHA, BETA-DICARBONYL COMPOUNDS WITH FLUOROGENIC PROBES

Biomarkers for cardiovascular diseases and methods using the same

ESCHERICHIA COLI AS A MARKER FOR HYPERTRIGLYCERIDEMIA

Milk fat globule epidermal growth factor 8 regulates fatty acid uptake

Lp(a) subform size identification using elisa

Method of measuring lipoprotein's capacity to accept cholesterol

in the gut microbiota and association with body weight

Use of MicroRNA or inhibitors thereof in regulation of lipid metabolism

Use of human small leucine zipper protein in adipocyte differentiation procedure

Alpha-keto-isovalerate as a biomarker of prebiotic efficacy for weight gain prevention

Indoxyl sulfate as a biomarker of prebiotic efficacy for weight gain prevention

Trimethylamine as a biomarker of prebiotic efficacy for weight gain prevention

Hexanoylglycine as biomarker for the predisposition for weight gain and obesity

Trimethylamine-N-oxide as biomarker for the predisposition for weight gain and obesity

MARKERS FOR LIPID METABOLISM

Isovalerylglycine as biomarker for the predispositon for weight gain and obesity

PC-O 44:4 - A BIOMARKER FOR VISCERAL ADIPOSITY

PC-O 42:4—a biomarker for visceral adiposity

METHOD FOR DETERMINING THE CONCENTRATION OF THE ADIPOCYTIC FORM OF THE FATTY ACID BINDING PROTEIN (A-FABP, FABP4, P2)

PC-O 44:6—a biomarker for visceral adiposity

PC-O 44:4—a biomarker for visceral adiposity

Compositions and methods for treating type III gaucher disease

Biomarkers for insulin resistance and methods using the same

IDENTIFICATION OF TWO NOVEL BIOMARKERS FOR NIEMANN-PICK DISEASE TYPE C

Methods of diagnosing a disease and methods of monitoring treatment of a disease by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker

Hepatic insulin sensitizing substance and test meal for insulin sensitization

Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity

Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity

Prevention and diagnosis of visceral fat

Use of leucyl tRNA synthetase

Droplet actuators and techniques for droplet-based enzymatic assays

Compositions and methods for treating Gaucher disease

Method of detection and treatment of clinically significant post-prandial hyperglycemia in normoglycemic patients

Method of treating a patient determined to be at risk of developing occult pancreatic beta-cell dysfunction

Molecular flux rates through critical pathways measured by stable isotope labeling In Vivo, as biomarkers of drug action and disease activity

Method for the diagnosis of Gaucher's disease

Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity

Non-precipitating bodily fluid analysis system

Method for Preventing Infection by a Virus

Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity

Inhibition of tat activating regulatory DNA-binding protein 43

Detection method

Methods of determining efficacy of cyclodextrin therapy

Modulation of ghrelin levels and ghrelin/unacylated ghrelin ratio using unacylated ghrelin

Pharmaceutical compositions comprising GPR119 agonists which act as peptide YY (PYY) secretagogues

DIAGNOSTIC METHODS FOR OBESITY AND RELATED DISORDERS

METHODS OF SUPPRESSING CANCER, INCREASING WEIGHT LOSS AND/OR INCREASING INSULIN SENSITIVITY

Compositions and methods for modulating dopamine neurotransmission

C-Met receptor regulation by angiotensin IV (AT4) receptor ligands

Method For Assaying Diseases Characterized By Dyslipidemia

Pharmacologic method of lowering cholesterol production

AMELIORATION OF METABOLIC SYNDROME USING PHYSIOLOGICAL FUNCTIONS OF SPHINGOMYELIN SYNTHASE SMS2, OR SCREENING METHODS FOR AMELIORATING AGENTS

TREATMENT OF OBESITY

Method and system for preventing virus-related obesity and obesity related diseases

APOLIPOPROTEIN A-1 MIMIC PEPTIDES, AND THERAPEUTIC AGENT FOR TREATING HYPERLIPIDEMIA AND DISEASES RELATED TO HYPERLIPIDEMIA COMPRISING SAME

Method for screening of therapeutic agent for hyperlipemia

Marker associated with non-alcoholic steatohepatitis

Compositions and methods for quantitatively monitoring lipids

ASSAY FOR PCSK9 INHIBITORS

RIP140 regulation of glucose transport

Biomarkers for monitoring insulin resistance and methods using the same

Methods of identifying candidate compounds of the human G protein-coupled receptor, GPR50, as modulators of body mass or adiposity

METHOD OF LIPID ASSAY AND REAGENT FOR USE THEREIN

HUMAN DIACYLGLYCEROL ACYLTRANSFERASE 2 (DGAT2) FAMILY MEMBERS AND USES THEREFOR

Trimethylamine-containing compounds for diagnosis and prediction of disease

Injection mould having a varying volume mould cavity

Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity

Use of Vgll3 activity modulator for the modulation of adipogenesis

Test agent for visceral obesity and use thereof

Method and kit for evaluation of predisposition to development of obesity, anti-obesity agent and method for screening thereof, non-human animal, adipose tissue, adipocyte, method for production of transgenic mouse, antigen, and antibody

Method of evaluating obesity, obesity-evaluating apparatus, obesity-evaluating method, obesity-evaluating system, obesity-evaluating program product, recording medium, and information communication terminal apparatus

Polymorphism in CYP3A4 gene affecting drug metabolizing and uses thereof

PHARMACEUTICAL COMPOSITIONS CONTAINING FLUORINATED OR PERFLUORINATED CARBOXYLIC ACIDS

PRODUCTION PROCESS OF GENDER-SPECIFIC SERUM AND BIOMARKER USING THE SERUM

ENPP1 (PC-1) GENE HAPLOTYPE ASSOCIATED WITH THE RISK OF OBESITY AND TYPE 2 DIABETES AND THEIR APPLICATIONS

Enterovirus Vaccines for Preventing and Treating Type 1 Diabetes (II)

Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor

METHOD OF LIPID ASSAY AND REAGENT FOR USE THEREIN

SIRT4 AND USES THEREOF

Diagnosis, prevention and treatment of disorders characterized by undesirable cell proliferation

Biomarkers of Mineralocorticoid Receptor Activation

MEX3C REGULATION AND TARGET TO CONTROL OBESITY AND DIABETES

Methods of identifying a modulator that inhibits the binding between Epstein-Barr virus induced receptor 2 and cholesterol derived ligands

Method, reagent and kit for measuring cholesterol in low-density lipoproteins

SIRT1 Modulation of Adipogenesis and Adipose Function

ASSAY FOR GENERATION OF A LIPID PROFILE USING FLUORESCENCE MEASUREMENT

GENE EXPRESSION PROFILES ASSOCIATED WITH LEAN PHENOTYPE AND USES THEREOF

Method and system for measuring a sample to determine the presence of and optionally treat a pathologic condition

Method and system for preventing virus-related obesity and obesity related diseases

PCSK9 inhibitors and methods of use thereof

MEANS AND METHODS DIAGNOSING GASTRIC BYPASS AND CONDITIONS RELATED THERETO

Prophylactic/therapeutic agents for lifestyle-related diseases

MODULATORS OF STAT3 SIGNALLING

Biomarkers for diabetes, obesity, and/or hypertension

METHOD OF MEASURING LIPID IN SPECIFIC LIPOPROTEIN

Compositions and methods for modulating dopamine neurotransmission

NICOTINIC ACID RECEPTOR LIGANDS

GENE SIGNATURES

Methods for modulating de novo hepatic lipogenesis by modulating XBP-1 activity

Methods of Reducing the Production of Reactive Oxygen Species and Methods of Screening or Identifying Compounds and Compositions that Reduce the Production of Reactive Oxygen Species

Method for evaluation or selection of adiponectin secretion regulator

Dietary Calcium for Reducing the Production of Reactive Oxygen Species

COMPOSITIONS AND METHODS FOR TREATING GAUCHER DISEASE

ANTI-BRAK (CXCL14) HUMAN MONOCLONAL ANTIBODY AND USE THEREOF

Biological substance nesfatin and its related substances and uses thereof

METHODS FOR IDENTIFYING DIABETES AND OBESITY THERAPEUTICS

METABOLIC FUEL SWITCHING BIOMARKER

METHODS AND COMPOSITIONS FOR UPREGULATION OF PEROXIREDOXIN ACTIVITY

Methods and compositions for characterization of HSD1 inhibitors

Small Molecule Intervention for Obesity

ADIPONECTIN EXPRESSION-INDUCING AGENTS AND USES THEREOF

System for predicting responsiveness to a pharmaceutical therapy for obesity

Structure of the insulin receptor ectodomain

Detecting phospholipidosis and diagnosing lysosomal storage disorders

TREATMENTS WITH HELMINTHS

Method for predicting responsiveness to a pharmaceutical therapy for obesity

Use of Lipocalin 2 in the Regulation of Insulin Sensitivity

Cholesterol-Regulating Complex of SIRT1 and LXR and Methods of Use

METHODS OF USING A G PROTEIN-COUPLED RECEPTOR TO IDENTIFY PEPTIDE YY (PYY) SECRETAGOGUES AND COMPOUNDS USEFUL IN THE TREATMENT OF CONDITIONS MODULATED BY PYY

Biomarkers for Appetite Regulation

Methods of using a G protein-coupled receptor to identify peptide YY (PYY) secretagogues

Method for screening a test substance for activating a receptor associated with FGF 21 activity

CONFORMATION AND ACTIVITY OF GBETA5 COMPLEXES

Method for Assessing the Risk of a Cardiovascular Disease and for Diagnosing Dyslipidemia

POINT VIBRATION THERAPY DEVICE

Altered Activity of Toll-Like Receptors

METHODS OF TREATING DISORDERS ASSOCIATED WITH FAT STORAGE

METHOD OF MEASURING LIPID IN SPECIFIC LIPOPROTEIN

MODIFIED ROUTES OF LIPID METABOLISM, MEASURING OXIDIZED LDL AFTER FAT LOADING

METHOD OF DIAGNOSING AND STRATIFYING ANTI-PHOSPHOLIPID SYNDROME

RIP140 regulation of diabetes

Regulation of lipid droplet formation by modulation of FIT1 and FIT2 and uses thereof

Injection moulding method

NOVEL OXIDIZED LDL COMPLEX AND METHOD FOR DETECTION THEREOF

METHOD OF EVALUATING COMPOUND EFFICACIOUS IN TREATING OBESITY BY USING Slc25a10

Animal having modification in MGAT2 gene

Assay

Methods of using GPR101 receptors to identify modulators of hypothalamic proopiomelanocortin (POMC)-derived biologically active peptide secretion

Non-precipitating bodily fluid analysis system

HUMAN DIACYLGLYCEROL ACYLTRANSFERASE 2 (DGAT2) FAMILY MEMBERS AND USES THEREFOR

Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis

Method for Evaluating Obesity Controller

Method for detection of familial combined hyperlipidemia

Methods of identifying candidate compounds of the human G protein-coupled receptor, GPR50, as modulators of body mass or adiposity

Isotope Detection and Uses Thereof

METHODS FOR DIAGNOSING AND PREDICTING NON-ALCOHOLIC STEATOHEPATITIS (NASH)

Biomarkers for Niemann-pick C disease and related disorders

Assay for generation of a lipid profile using fluorescence measurement

SERUM AMYLOID A PROTEIN IN INFLAMMATION AND OBESITY

Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor

Methods of using GPR119 to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY

METHODS OF USING QUANTITATIVE LIPID METABOLOME DATA

Methods for modulating de novo hepatic lipogenesis by modulating XBP-1 activity

METHOD OF PRETREATMENT OF SAMPLE FOR QUANTITATING CHOLESTEROL AND METHOD FOR QUANTITATING CHOLESTEROL IN SPECIFIC LIPOPROTEINS BY USING THE SAME

Increasing glucose transport and insulin-stimulated glucose uptake

METABOLITE MARKERS FOR WEIGHT MANAGEMENT

METHODS TO IDENTIFY FAT AND LEAN ANIMALS USING CLASS PREDICTORS

Polymer and method of measuring cholesterol therewith

Methods for metabolic modulation

Adiponectin for treatment of various disorders

Multiple quantification of cholesterol in low density lipoprotein

Chemokine antagonists as treatment for obesity-related and metabolic syndrome-related conditions

Auto-antibodies against the melanocortin-4 receptor

Method for determining the concentration of the adipocytic form of the fatty acid binding protein (A-FABP, FABP4, P2)

NOVEL USE OF G-PROTEIN-CONJUGATED RECEPTOR AND LIGAND THEREOF

Diagnosis, prevention, and/or treatment of atherosclerosis and underlying and/or related diseases

Method for determining insulin sensitivity with biomarkers

Method of quantitatively measuring small particle low density lipoproteins

Methods of diagnosis and treatment of metabolic disorders

MULTIDIMENSIONAL MASS SPECTROMETRY OF SERUM AND CELLULAR LIPIDS DIRECTLY FROM BIOLOGIC EXTRACTS

Method Of Diagnosing A Body Weight Condition Or Predisposition

Measurement of melanocortin peptides and uses thereof

LXR ligand testing method

Method for treating insulin sensitivity by long-acting GLP-1 receptor mimetibody agonists

Association of SNPs with fat deposition and fatty acid composition

Compounds and Methods for Treating Obesity

Use of haptoglobin genotyping in diagnosis and treatment of defective reverse cholesterol transport (RCT)

NPC1L1 AND NPC1L1 INHIBITORS AND METHODS OF USE THEREOF

Method for activating efferent sympathetic nerves innervating adipose tissues to improve obesity and symptoms associated therewith

C-Met receptor regulation by angiotensin IV (AT) receptor ligands

Method for Determining Insulin Sensitivity and Glucose Absorption

Methods and compositions for treating obesity

METHOD OF MEASURING LIPID DROPLETS AND APPLICATIONS OF USING THE SAME

Compositions and Methods For Modulating Dopamine Nerutransmission

METHOD OF LIPID ASSAY AND REAGENT FOR USE THEREIN

Methods for modulating the sensation of satiety perception and agents useful for same

Cholesterol Assay

Assay For Lipoproteins Using Lumiphore K-37

Drugs For Diseases Accompanying Changes In Total Bile Acid Pool Or Lipid Metabolism Disorders And Method Of Screening These Drugs

Biological substance nesfatin and its related substances and uses thereof

Dry test strip with controlled flow and method of manufacturing same

Method of Screening Antiobesity Agents

Obesity gene and use thereof

Thermoelectric sensor for analytes in a fluid and related method

Methods and compositions for inhibiting ER-stress induced cholesterol/triglyceride accumulation

Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins

Method and composition for management of weight and blood sugar

Acetyl CoA Carboxylase Splice Variant and Uses Thereof

Cholesterol transport gene

CMKLR regulation of adipogenesis and adipocyte metabolic function

Methods and Compositions for Modulating Satiety

Device and method for analysis of a metabolic malady

Pharmacologic Method Of Lowering Cholesterol Production

Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins

Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins

Human Obesity Susceptibility Gene and Uses Thereof